Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening

Eur Radiol. 2014 Oct;24(10):2412-6. doi: 10.1007/s00330-014-3278-7. Epub 2014 Jun 28.


Numerous studies established high mammographic density (MD) as a significant breast cancer risk. By adopting both radiological and epidemiological perspectives, we analysed the capacity of this radiological parameter to express an individual level of risk and the methods for assessing the relationship between MD categories and risk. MD is unable to identify individual underlying anatomical and physiological components. Many factors affect accurate and reproducible measurements and consequently classifications of MD. Significant relative risks were found by comparing the MD categories in the tails of distribution (i.e. the group of women with the lowest MD to that with the highest MD), which represent <10 % of women in each group: the majority of the population was ignored. When a relevant threshold of MD was applied to compare another group and the entire population was included to compare the two groups, some studies showed no significant or only moderate relative risk (RR) between women with readings above and those below the threshold. Sensitivity and specificity remain unknown. MD cannot be considered a worthwhile test by which to categorically identify high-risk women in screening. Key points • Unknown individual anatomical and physiological components do not express the risk level.• The epidemiological conditions are not relevant to distinguish a high-risk category.• The most relevant studies show no or moderate risks.

Publication types

  • Review

MeSH terms

  • Breast Density
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / diagnostic imaging*
  • Female
  • Humans
  • Mammary Glands, Human / abnormalities*
  • Mammography / methods*
  • Mass Screening / methods*
  • Risk Factors